SCHEMBL20168228

SCHEMBL20168228

COc1c(O)cccc1C(=N)Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
LMNA P02545 4/20 0.45
MAPT P10636 3/20 0.45
ALDH1A1 P00352 3/20 0.45
TP53 P04637 2/20 0.45
CYP3A4 P08684 2/20 0.45
HPGD P15428 2/20 0.45
ALOX15 P16050 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TSHR P16473 2/20 0.42
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
DRD2 P14416 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27531684 0.82 KMT2A (0.53) LMNAMAPTALDH1A1TP53HPGD
SCHEMBL28185314 0.81 CA1 (0.46) CA1CA2LMNAMAPTALDH1A1
SCHEMBL16950841 0.78 CA1 (0.50) CA1CA2LMNAMAPTALDH1A1
2-Methoxyresorcinol SCHEMBL69297 0.76 CA2 (0.61) CA1CA2LMNAMAPTALDH1A1
SCHEMBL20342786 0.74 CA1 (0.52) CA1CA2LMNAMAPTALDH1A1
SCHEMBL470708 0.74 CA1 (0.54) CA1CA2LMNAMAPTALDH1A1
SCHEMBL10433490 0.74 CA1 (0.47) CA1CA2LMNAMAPTALDH1A1
2-Methoxyresorcinol SCHEMBL10818280 0.74 CA2 (0.59) CA1CA2LMNAMAPTALDH1A1
SCHEMBL9957714 0.74 TRPA1 (0.48) CA1CA2LMNAMAPTALDH1A1
Methyl 3-Hydroxy-2-Methoxybenzoate SCHEMBL1050662 0.73 LMNA (0.66) CA1CA2LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541390-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS Cystic Fibrosis Foundation Therapeutics Inc. (US) 2019-09-25 EP disclosed
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed